WuXi XDC Cayman Inc. ('WuXi XDC' or the 'Company', stock code: 2268.HK), a leading global CRDMO (Contract Research, ...

WuXi AppTec Co. posted better-than-expected third-quarter revenue despite concerns over a US bill seeking to block the ...

As the Chinese contract manufacturer awaits the U.S. Senate’s consideration of the BIOSECURE Act, it has added 800 new ...

The 2024 Taihu Bay Wuxi Low-Altitude Economy Innovation and Development Conference took place in Wuxi, Jiangsu province, on ...

A hospital in Wuxi, Jiangsu province has been fined 58.95 million yuan ($8.24 million) and stripped of its operating license ...

Planegg/Martinsried, November 11, 2024.Medigene AG (Medigene or the “Company”, FSE: MDG1, Prime Standard), an oncology platform company focused ...

WuXi Biologics ("WuXi Bio") (2269.HK), a leading global Contract Research, Development, and Manufacturing Organization (CRDMO ...

About 30 media workers and influencers embarked on a media tour on Nov 5 at the renovated Nanquan Old Street in Wuxi, East ...

"We are delighted to receive the 2024 Global CRDMO Company of the Year Award from Frost & Sullivan," said Dr. Ge Li, Chairman and CEO of WuXi AppTec. "WuXi AppTec is committed to enhancing our unique ...

WuXi occupies nearly 400,000 square feet across three buildings at the Navy Yard, where it has about 800 employees. China-based pharmaceutical company WuXi AppTec is considering the sale of its ...

WuXi AppTec Co. posted better-than-expected third-quarter revenue despite concerns over a US bill seeking to block the Chinese company from accessing federally-funded contracts. While the company ...

SHANGHAI, Oct. 29, 2024 /PRNewswire/ -- WuXi AppTec, a global company that provides a broad portfolio of R&D and manufacturing services to enable companies in the pharmaceutical and life science ...